Tue June 11 – 10 Stories of The Day!
11 Jun, 2019 | 03:42h | UTC
Commentaries: Three public health interventions could prevent 94 million premature deaths – Harvard T.H. Chan School of Public Health (free) AND 3 simple steps could save 94 million lives – American Heart Association News (free) AND Lowering blood pressure, sodium intake may prevent 94 million early deaths – UPI (free)
2 – Cardiovascular Events and Mortality in White Coat Hypertension: A Systematic Review and Meta-analysis – Annals of Internal Medicine (link to abstract – $ for full-text)
Commentaries: People with Untreated “White Coat Hypertension” Twice as Likely to Die from Heart Disease – Penn Medicine (free) AND Untreated white-coat hypertension associated with increased cardiovascular and mortality risk – ACP Internist (free) AND Patients whose blood pressure only spikes at the doctor’s office are twice as likely to die of a heart attack or other cardiac event – STAT (free)
3 – Top 10 medical myths, busted – ACP Internist (free)
“Ten medical myths persist despite all the evidence.”
4 – Incidence of Herpes Zoster Among Children: 2003–2014 – Pediatrics (link to abstract – $ for full-text)
Commentaries: When kids are vaccinated against chickenpox, they’re less likely to get shingles, too – STAT (free) AND Decline in pediatric herpes zoster associated with varicella vaccine – 2 Minute Medicine (free)
5 – Editorial: ICD 11 – The Lancet (free)
Related: WHO: ICD-11 is Here! (free resources)
6 – Perspective: The war to free science – Vox (free)
Related: Plan S: Making Full and Immediate Open Access a Reality (free resources) AND Open Access 2018: A Year of Funders and Universities Drawing Lines in the Sand (free resources)
“How librarians, pirates, and funders are liberating the world’s academic research from paywalls.”
7 – Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial – The Lancet (link to abstract – $ for full-text)
Commentary: Dulaglutide Cuts Cardiovascular Risk in Type 2 Diabetes – NEJM Journal Watch (free)
During a median follow-up of 5.4 years, the primary outcome (a composite endpoint of non-fatal myocardial infarction, non-fatal stroke, or death from cardiovascular causes) occurred in 12.0% of participants in the dulaglutide group and in 13.4% of participants in the placebo group (incidence rate of 2.4 per 100 person-years vs 2.7 per 100 person-years in the placebo group).
8 – Effect of a Self-management Support Intervention on Asthma Outcomes in Older Adults: The SAMBA Study Randomized Clinical Trial – JAMA Internal Medicine (free for a limited period)
Commentary: Study reports asthma control in older patients and shows lower ED visits – The Mount Sinai Hospital (free)
9 – Risk of Hospitalization for Serious Adverse Gastrointestinal Events Associated With Sodium Polystyrene Sulfonate Use in Patients of Advanced Age – JAMA Internal Medicine (free for a limited period)
Editorial: Sodium Polystyrene Sulfonate for Hyperkalemia (free)
Commentary: Sodium Polystyrene Sulfonate Tied to Increased Risk for Serious GI Events in Seniors – NEJM Journal Watch (free)
10 – Association of Exposure to Artificial Light at Night While Sleeping With Risk of Obesity in Women – JAMA Internal Medicine (free for a limited period)
Commentaries: Sleeping with artificial light at night associated with weight gain in women – NIH News Releases (free) AND Sleeping with lights or TV on tied to obesity – Reuters (free) AND Sleeping with the TV on may make you gain weight – Associated Press (free)